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A B S T R A C T
Background: This study was conducted to assess the prevalence and characterization of CAD in high risk
patients requiring pacemaker implantation for symptomatic bradyarrhythmias.
Methods: This study included 100 patients with symptomatic sinus node dysfunction or atrioventricular
block, who were at high risk of CAD or had previously documented atherosclerotic vascular disease
(ASCVD). Coronary angiography was performed before pacemaker implantation. CAD was deﬁned as the
presence of any degree of narrowing in at least one major coronary artery or its ﬁrst order branch.
Obstructive CAD was deﬁned as 50% diameter stenosis. CAD was categorized as single vessel disease
(SVD), double vessel disease (DVD), or triple vessel disease (TVD); and obstructive CAD in the arteries
supplying the conduction system was sub-classiﬁed according to Mosseri’s classiﬁcation.
Results: Out of 100 patients (mean age 64.6  10.7 years), 45 (45%) had CAD. 29% patients had obstructive
CAD while 16% had non-obstructive CAD. 53.3% patients had SVD, 15.6% had DVD and 31.1% had TVD. Among
patients with obstructive CAD; Type I, II, III and IV coronary anatomies were present in 6.9%, 34.5%, 10.3% and
48.3% patients respectively. Presence of CAD signiﬁcantly correlated with dyslipidemia (p = 0.047), history of
smoking (p = 0.025), and family history of CAD (p = 0.002).
Conclusion: Angiographic CAD is observed in a substantial proportion of patients with symptomatic
bradyarrhythmias and risk factors for CAD. It could be argued that such patients should undergo a
coronary work-up before pacemaker implantation. Treatment of concomitant CAD is likely to improve
the long term prognosis of these patients.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Bradyarrhythmias, deﬁned as heart rate below 60 beats per
minute, are a common clinical occurrence and comprise of aAbbreviations: ACCF, American College of Cardiology Foundation; AHA, American
Heart Association; ASCVD, Atherosclerotic Vascular Disease; CAD, coronary artery
disease; CHD, coronary heart disease; HRS, Heart Rhythm Society; SPECT, single
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creativecommons.org/licenses/by-nc-nd/4.0/).variety of rhythm disorders including sinus node dysfunction
(SND) and atrioventricular (AV) conduction disturbances or
blocks.1,2 These disorders can result from various intrinsic and
extrinsic conditions causing damage to the conduction system.
Furthermore, bradycardia can be a normal physiologic response
under certain circumstances (during sleep, healthy athletes).
Clinical presentation of bradyarrhythmias ranges from asymp-
tomatic electrocardiographic (ECG) ﬁndings to a broad array of
symptoms which may be typical (syncope, near syncope) or
atypical (dyspnea, angina, dizziness, fatigue, lethargy).2 Symptoms
can be either permanent or intermittent and unpredictable. Many
individuals with conduction system disorder are asymptomatic
and never seek medical attention.3,4 As far as etiology of
bradyarrhythmias is concerned, it is difﬁcult to ascribe conduction
system disease to a speciﬁc cause, in a substantial proportion oferization of coronary artery disease in patients with symptomatic
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.06.013
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disease, usually ischemic, a cause-and-effect relationship is
difﬁcult to document. In fact, unless the conduction defect
occurred in the setting of acute myocardial infarction, histologic
examination of the conduction system in most of these individuals
shows nonspeciﬁc scarring and fatty inﬁltration regardless of the
presence or absence of underlying ischemic heart disease.5
Previous studies have suggested that histologic changes in the
conduction system are insufﬁcient to explain the disorder, leading
to the assumption that associated disease conditions like coronary
atherosclerosis, hypertensive cardiovascular disease, congenital
heart disease or myocardial disease, may have an important role in
the pathogenesis of these disorders.5,6
The prevalence of coronary artery disease (CAD) in chronic
conduction disorders has been reported to be 15–70%, depending
on patients characteristics and the diagnostic modality used to
detect CAD.7–10 Although dobutamine stress echocardiography
(sensitivity – 88%, speciﬁcity – 92%) and exercise thallium-201
myocardial SPECT (sensitivity – 94%, speciﬁcity – 31%) have been
used to diagnose CAD in patients with transvenous pacemakers,
coronary angiography remains the ‘gold standard’ for conﬁrming
diagnosis.10 Beyond its possible causative role, the presence of CAD
makes the prognosis of conduction disorder worse.11,12 Moreover,
since patients with symptomatic complete heart block or sick sinus
syndrome may not develop angina owing to their low heart rate,
the underlying CAD may remain undiagnosed or underdiagnosed,
which in turn may have serious implications on their clinical
outcomes despite treatment of bradycardia with permanent
pacemaker implantation. This study was conducted with an aim
of assessing the prevalence and characterization of CAD in high risk
patients requiring permanent pacemaker implantation for symp-
tomatic bradyarrhythmias. To the best of our knowledge, there is
very limited data of such nature available among Indian
population. We believe that it is important and useful to have
such data for formulating appropriate method of care in such
patients.
2. Patients and methods
2.1. Study design
This single-center hospital based prospective observational
study, was conducted in the Department of Cardiology, Sher-i-
Kashmir Institute of Medical Sciences, Srinagar, Jammu and
Kashmir, between 2012 and 2015.
2.2. Study population
We enrolled consecutive patients requiring permanent pace-
maker implantation for symptomatic sinus node dysfunction or
atrioventricular blocks who fulﬁlled the eligibility criteria as
described below.
2.2.1. Inclusion criteria
i. Patients above the age of 40 years with symptomatic sick sinus
syndrome or conduction disorders, who fulﬁlled the ACCF/AHA/
HRS criteria for permanent pacemaker implantation.13
ii. Patients deemed to be at high risk for CAD or previously
documented ASCVD (fulﬁlling one or more of following
criteria).
a. High Framingham risk score (10 year CHD risk  20%).14
b. Two or more than two conventional risk factors including
hypertension (deﬁned as patient taking any anti-hypertensive
drugs at the time of presentation or if blood pressure recorded
was 140 mmHg systolic and/or 90 mmHg diastolic, on atPlease cite this article in press as: Alai MS, et al. Prevalence and charact
bradyarrhythmias requiring pacemaker implantation, Indian Heart Jleast two separate occasions); type-2 diabetes mellitus
(diagnosed on the basis of fasting plasma glucose of
126 mg/dL or Hemoglobin A1C greater than 6.5% or
symptoms of diabetes plus random blood glucose concentra-
tion 200 mg/dL or patient on anti-diabetic medications);
obesity (body mass index > 30 kg/m2 body surface area);
history of angina; smoking (deﬁned as if the patient smoked
>1 cigarette per day regularly for more than 6 months or had
quit smoking for less than 2 years); dyslipidemia (deﬁned as
total cholesterol 200 mg/dL, or LDL cholesterol 130 mg/dL,
or triglycerides 150 mg/dL, or HDL cholesterol 40 mg/dL or
any combination of these criteria); age (male  45 years and
females  55 years); and positive family history of CAD.
c. Previous history of ASCVD, including CAD (documented on
angiography), stroke, transient ischemic attack (TIA), pe-
ripheral vascular disease (PVD), abdominal aortic aneurysm,
chronic kidney disease (CKD), percutaneous coronary
intervention (PCI), coronary artery bypass grafting (CABG)
or familial hypercholesterolemia.
iii. Patients who gave consent for the study.
2.2.2. Exclusion criteria
i. Acute illness including acute coronary syndrome (ACS),
myocarditis, infective endocarditis or sepsis.
ii. History of chronic diseases known to cause conduction
disturbances like connective tissue disorders, inﬁltrative
disorders, muscle dystrophies or systemic malignancies.
iii. Intake of drugs known to cause bradyarrhythmias like digoxin,
beta blockers, calcium channel blockers or anti-arrhythmic
medications.
iv. Presence of severe anemia, coagulopathy, end stage renal
disease (ESRD) or dyselectrolemia.
v. Patients with congenital heart disease (including congenital
heart block), valvular heart disease or cardiomyopathy.
vi. History of allergy to contrast agents.
vii. Patients who refused to give consent for the study.
2.3. Methods
A detailed history including presenting symptoms, past
history, family history of CAD or conduction disorders, history
of atherosclerotic risk factors and drug history was taken from
all patients. Complete physical examination including cardio-
vascular examination was then performed. Base line investiga-
tions including electrocardiogram (ECG), complete blood count,
kidney function tests, liver function tests, arterial blood gas
analysis, serum electrolytes, lipid proﬁle, serum uric acid,
fasting blood sugar, thyroid proﬁle, coagulation proﬁle were
obtained. Echocardiography to rule out signiﬁcant structural
heart disease or cardiomyopathies and to assess left ventricular
function was also done in all the cases. Risk calculation was
done according to the Framingham coronary heart disease risk
score and only patients having high risk (10 year CHD risk 20%)
were included in the study.14 One day prior to pacemaker
implantation, coronary angiography (CAG) was performed via
trans-radial or trans-femoral approach using the standard
Judkins technique. The angiograms were assessed by two
independent interventional cardiologists who were blinded to
the clinical details of the patients. Coronary artery disease was
deﬁned as the presence of any degree of narrowing in at least
one major coronary arteries [left anterior descending (LAD), left
circumﬂex (LCx), right coronary artery (RCA)] or their ﬁrst order
branches. Obstructive CAD was deﬁned as 50% diametererization of coronary artery disease in patients with symptomatic
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.06.013
Table 1
Correlation of presenting symptoms with presence or absence of CAD.
Presenting complaints Coronary artery disease
(Total = 100)
p value
Absent (n = 55) Present (n = 45)
Syncope [n (%)] 37 (62.27%) 33 (73.33%) 0.511
Pre syncope [n (%)] 17 (30.90%) 12 (26.67%) 0.642
Chest pain [n (%)] 10 (18.18%) 15 (33.33%) 0.082
Dyspnea [n (%)] 8 (14.54%) 10 (22.22%) 0.320
Palpitations [n (%)] 4 (7.27%) 4 (8.89%) 1.000
CAD – coronary artery disease; n – number; % – percentage.
Table 2
Distribution of risk factors among patients with and without CAD.
Risk factors Coronary artery disease
(Total = 100)
p value
Absent (n = 55) Present (n = 45)
Hypertension [n (%)] 47 (85.45%) 41 (91.11%) 0.387
Diabetes [n (%)] 15 (27.27%) 10 (22.22%) 0.562
Obesity [n (%)] 3 (5.45%) 3 (6.67%) 1.000
Smoking [n (%)] 16 (29.09%) 23 (51.11%) 0.025
Dyslipidemia [n (%)] 13 (23.64%) 19 (42.22%) 0.047
Family history [n (%)] 7 (12.72%) 20 (44.44%) 0.002
CAD – coronary artery disease; n – number; % – percentage.
Table 3
Correlation between type of bradyarrhythmia and coronary artery disease.
Bradyarrhythmias Coronary artery disease
(Total = 100)
p value
Absent (n = 55) Present (n = 45)
Complete heart block [n (%)] 29 (52.72%) 29 (64.44%) 0.374
Sinus node dysfunction [n (%)] 7 (12.72%) 4 (8.89%)
Second degree heart block [n (%)] 4 (7.27%) 5 (11.11%)
Trifasicular block [n (%)] 2 (3.64%) 3 (6.67%)
Bifasicular block [n (%)] 13 (23.64%) 4 (8.89%)
n – number; % – percentage.
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the adjacent normal segment) in any of these vessels, while
50% diameter stenosis was labeled as non-obstructive CAD.
CAD was categorized as single vessel disease (SVD), double
vessel disease (DVD), or triple vessel disease (TVD) according to
number of major branches with atherosclerotic involvement.
Among patients with obstructive CAD, the location of stenosis in
the LAD and RCA, as the arteries supplying the conduction
system, was classiﬁed according to Mosseri et al.’s classiﬁca-
tion.11 Type I. Anatomy not compromising blood supply to the
conduction system, namely, either the absence of signiﬁcant
narrowing in the LAD, RCA, LCx, posterolateral ventricular (PLV),
or posterior descending artery (PDA) or the presence of mid-
distal LAD lesions beyond the septal branches. Type
II. Pathological coronary anatomy involving septal branches
emerging from the LAD, without signiﬁcant lesions in the RCA.
Type III. Pathological coronary anatomy compromising blood
supply to the sinoatrial (SA) nodal or AV nodal branches but not
compromising blood ﬂow to the septal branches. This subset
includes patients with distal LAD lesions after the septal
branches. Type IV. Combination of Type II and Type III
pathological coronary anatomy that compromises blood supply
both to the septal branches and SA or AV arteries. We also
studied the correlations of various clinical and demographic
variables with the presence or absence of CAD in these patients.
2.4. Consent and ethical issues
After explaining the study in detail, an informed consent was
taken from each patient. The study protocol was cleared by the
Institutional Ethics Committee. As a part of study protocol, the cost
of CAG was exempted by the hospital administration.
2.5. Statistical analysis
Statistical analysis was performed by SPSS software package
(version 20.0, SPSS Inc, Chicago, Illinois, USA). All continuous
variables were expressed as mean  SD, and categorical variables
were reported as frequency and percentages. Group comparisons
were performed with Student t-test or crosstabs. The Chi-square test
or Fisher exact test was used for categorical variables. A p-value of
<0.05 was considered statistically signiﬁcant.
3. Results
During the study period of 3 years, a total of 100 patients with
symptomatic bradyarrhythmias requiring permanent pacemaker
implantation and at high risk of CAD or previously documented
ASCVD were enrolled in the study.
3.1. Patient characteristics
The mean age of our patients was 64.6  10.7 years, ranging
from 40 to 95 years. Out of 100 patients 53 were males and 47 were
females. Complete heart block was present in 58 patients, 11 patients
had sick sinus syndrome, second degree heart block was seen in
9 patients, trifascicular block was present in 5 patients, and
17 patients had bifascicular block.
3.2. Frequency and distribution of coronary artery disease
Out of 100 patients, 45 were documented to have CAD on
coronary angiography while 55 did not have CAD. Out of
45 patients with CAD, 29 had obstructive CAD and 16 had non-
obstructive CAD. In terms of the number of vessels involved,
24 patients (53.3%) had single vessel disease (SVD), 7 patientsPlease cite this article in press as: Alai MS, et al. Prevalence and charact
bradyarrhythmias requiring pacemaker implantation, Indian Heart J(15.6%) had double vessel disease (DVD) and 14 patients (31.1%)
had triple vessel disease (TVD). When coronary anatomy of the
patients with obstructive CAD was categorized according to
Mosseri’s classiﬁcation; 2 patients (6.9%) had Type I coronary
anatomy, 10 patients (34.5%) had Type II coronary anatomy,
3 patients (10.3%) had Type III coronary anatomy, and 14 patients
(48.3%) had Type IV coronary anatomy.
3.3. Clinico-demographic correlates of coronary artery disease
To study the correlation of CAD with various clinical and
demographic variables, we divided the patients into two groups;
Group I (Patients without CAD) and Group II (Patients with CAD).
As described in Table 1, we found that presence of CAD on coronary
angiography was signiﬁcantly correlated with dyslipidemia
(p = 0.047), history of smoking (p = 0.025), and family history of
CAD (p = 0.002). There was no signiﬁcant correlation between CAD
and age (p = 0.228), sex (p = 0.841), hypertension (p = 0.387),
diabetes (p = 0.562), obesity (p = 1.000), or past history of ASCVD
(p = 0.200). Presence of CAD was also not correlated with
presenting symptoms (Table 2) including syncope (p = 0.511),
pre-syncope (p = 0.642), chest pain (p = 0.082), dyspnea
(p = 0.958), or palpitations (p = 0.767). As depicted in
Tables 3 and 4, we also did not ﬁnd any signiﬁcant correlation
between CAD and type of bradyarrhythmia (p = 0.374) or number
of risk factors present (p = 0.228).erization of coronary artery disease in patients with symptomatic
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.06.013
Table 4
Correlation between number of risk factors and coronary artery disease.
Number of risk factors Coronary artery disease
(Total = 100)
p value
Absent (n = 55) Present (n = 45)
Two
[n (%)]
36 (65.45%) 36 (80.00%) 0.228
Three
[n (%)]
15 (27.27%) 8 (17.78%)
Four
[n (%)]
4 (7.27%) 1 (2.22%)
n – number; % – percentage.
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The main ﬁndings of our study were:
i. Angiographic CAD was observed in nearly half (45%) of the
patients requiring permanent pacemaker implantation for
symptomatic bradyarrhythmias and risk factors for CAD, and
nearly one third (29%) had obstructive CAD.
ii. In patients with obstructive CAD, Type IV and Type II coronary
anatomies (according to Mosseri et al.’s classiﬁcation) were
most common (48.3% and 34.5% respectively).
iii. Presence of CAD was signiﬁcantly correlated with dyslipidemia
(p = 0.047), history of smoking (p = 0.025), and family history of
CAD (p = 0.004).
Bradyarrhythmias and conduction system disorders are preva-
lent among middle age and elderly population and many of these
patients are also at high risk of having CAD. Bradyarrhythmia is
often observed in patients with acute myocardial infarction or
coronary artery bypass graft, and in patients experiencing
transient exercise-induced ischemia.15–18 Conversely, the preva-
lence of CAD in chronic conduction disorders has been reported to
be 15–70%, depending on patients’ characteristics, diagnostic
modality and criteria used to deﬁne CAD.7–10 In a necropsy series of
100 patients with chronic heart block, Davies MJ reported that only
15% of the patients had CAD of sufﬁcient severity to account for the
heart block.7 Hsueh et al. performed coronary angiography non
selectively in 113 patients with symptomatic bradyarrhythmias
and found incident CAD in 20% of these patients.8 Brueck et al., in
an angiographic study of 507 patients requiring pacemaker
implantation and at least one atherosclerotic risk factor, found a
remarkable 71% incidence of CAD in such patients.9 Our study
revealed an overall 45% incidence of CAD and 29% incidence of
signiﬁcant CAD in these patients. Considering all these data
together, we conclude that although chronic CAD is not considered
to be a dominant cause of conduction system disturbances in
current clinical practice, the incidence of CAD in patients with
symptomatic bradyarrhythmias requiring permanent pacemaker
implantation and risk factors for CAD is quite high. Although the
justiﬁcation of performing invasive coronary angiography could be
debated (considering its cost and risks), we suggest some form of
CAD screening in these patients, before pacemaker implantation.
The diagnosis of CAD in this patient group has potentially
signiﬁcant clinical implications. First, CAD may have an etiological
role in the genesis of these rhythm disturbances. According to the
previous studies, one-third of patients with sinus node dysfunction
and 15% of patients with chronic atrioventricular block could be
attributed to the underlying chronic CAD.7,19 Having said that,
revascularization in patients with coexistent CAD and conduction
disorders has been shown to have little or no impact on the
reversibility of conduction disturbances in all but one study.20–23 It
is widely believed that the ischemic damage to the conductionPlease cite this article in press as: Alai MS, et al. Prevalence and charact
bradyarrhythmias requiring pacemaker implantation, Indian Heart Jsystem in chronic CAD is permanent and does not reverse with
revascularization. However, a study conducted by Zhong et al. in
patients with ‘symptom-free’ bradyarrhythmias and associated
signiﬁcant CAD demonstrated that PCI delayed the demand for
pacemaker implantation among these patients when compared to
a similar control group who did not undergo revascularization.23
Given the results of this study and the fact the 29% of our patients
had obstructive CAD, it would be worthwhile to perform a
randomized case control study among Indian patients who have
signiﬁcant CAD and conduction system disturbances, that do not
immediately require pacemaker implantation, to see the effect of
revascularization on the same. Second, concomitant CAD has a
major prognostic impact on these patients. Although symptoms
related to bradycardia improve in most patients after pacemaker
implantation, those with coexistent CAD have worse outcomes in
the long-term.12,24,25 Risk factor modiﬁcation, guideline directed
medical therapy and revascularization, when indicated, is likely to
reduce CAD related mortality and morbidity in these patients.
Finally, after permanent pacing, certain other issues among
patients with coexistent CAD deserve attention. The distorted
electrocardiography of a pacemaker-dependent patient makes it
invalid for the diagnosis of myocardial ischemia or infarction,
making it compulsory to use alternative and more expensive
modalities for such purposes. Additionally, increased or ﬁxed heart
rate, a loss of AV synchrony, and abnormal contraction and
relaxation patterns of the left ventricle after cardiac pacing may
aggravate underlying myocardial ischemia.26,27 Hence, in patients
with symptomatic bradyarrhythmia demanding permanent pace-
maker implantation, early diagnosis of coexistent CAD is important
for adequate pacemaker-mode selection and better patient care.
In an attempt to characterize the coronary anatomy in patients
on permanent artiﬁcial pacemakers, Mosseri et al. devised a
classiﬁcation (described in Section 2.3), keeping in mind the blood
supply of the various components of cardiac conduction system.11
In their initial study, they found that Type II and Type IV
pathological coronary anatomies, compromising blood ﬂow to the
septal branches of LAD or both septal branches and RCA
respectively, were most frequently observed in these patients.
This was subsequently conﬁrmed in other studies by Tandogan
et al.,28 Yesil et al.,29 and Wei et al.30 Our study revealed that Type
IV coronary anatomy was most common (48.3%) followed by Type
II anatomy (34.5%), while Type III and Type I were relatively
uncommon, accounting for 10.3% and 6.9% cases of obstructive
CAD respectively. These ﬁndings were consistent with previous
studies. We also found that presence of CAD in these patients was
signiﬁcantly correlated with dyslipidemia, history of smoking, and
family history of CAD. Hence, the presence of these risk factors
should further prompt us to perform coronary work-up in such
patients. Also, presence of CAD had no signiﬁcant correlation with
age, presence of diabetes, hypertension, obesity or past history of
ASCVD (known to be strongly associated with CAD). Whether this
lack of signiﬁcant association was due to small sample size or
ethnic attributes of Kashmiri population needs to be conﬁrmed by
larger studies. To conclude, we would like to stress that even
though the conduction disturbances may not reverse with
revascularization, appropriate management CAD with pharmaco-
logical or non-pharmacological therapy is likely to improve the
long term outlook of these patients.
5. Conclusion
Angiographic CAD is observed in a substantial proportion of
patients with symptomatic bradyarrhythmias and risk factors for
CAD. It could be argued that these patients should undergo a
coronary work-up before pacemaker implantation. Diagnosis and
appropriate management of concomitant CAD is likely to improveerization of coronary artery disease in patients with symptomatic
. (2016), http://dx.doi.org/10.1016/j.ihj.2016.06.013
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beneﬁts derived from pacing.
6. Limitations
The present study had some important limitations. First, this was
a single center study with a small sample size, and there was no
control group. Therefore, extrapolation of these results to general
population requires further validation from larger prospective
multi-center studies. Second, only patients who were admitted for
permanent pacemaker implantation were included in the study. The
association of CAD with asymptomatic and less severe conduction
disturbances needs to be studied further. Lastly, we did not assess
the effect of revascularization on the outcome of these patients. Long
term follow up needs to be done to quantify the prognostic beneﬁt
derived from revascularization in this patient group.
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Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ihj.2016.06.013.
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